CDKN2B and hepatocellular carcinoma: We then investigated potential correlations between CDKN2B‐AS1 genetic polymorphisms and various clinicopathological features, including clinical stage, primary tumour size, lymph node and distant metastases, vascular invasion, hepatitis virus infection and liver cirrhosis among all HCC patients.